Neurometrix Company Profile (NASDAQ:NURO)

About Neurometrix (NASDAQ:NURO)

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Symbol: NASDAQ:NURO
CUSIP: N/A
Web: www.neurometrix.com

Capitalization:

Market Cap: $4.37 million
Outstanding Shares: 1,268,000

Average Prices:

50 Day Moving Avg: $1.59
200 Day Moving Avg: $0.99
52 Week Range: $0.45 - $18.88

P/E:

Trailing P/E Ratio: N/A
Foreward P/E Ratio: -1.26
P/E Growth: -0.02

Sales & Book Value:

Annual Revenue: $14.06 million
Price / Sales: 0.31
Book Value: $7.19 per share
Price / Book: 0.48

Profitability:

EBIDTA: ($14,270,000.00)
Net Margins: -124.01%
Return on Equity: -181.47%
Return on Assets: -129.09%

Debt:

Current Ratio: 2.29%
Quick Ratio: 1.91%

Misc:

Average Volume: 183,046 shs.
Beta: 0.1
Short Ratio: 3.66

Frequently Asked Questions for Neurometrix (NASDAQ:NURO)

What is Neurometrix's stock symbol?

Neurometrix trades on the NASDAQ under the ticker symbol "NURO."

When did Neurometrix's stock split? How did Neurometrix's stock split work?

Shares of Neurometrix reverse split on the morning of Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. An investor that had 100 shares of Neurometrix stock prior to the reverse split would have 13 shares after the split.

How were Neurometrix's earnings last quarter?

Neurometrix Inc (NASDAQ:NURO) issued its earnings results on Thursday, April, 20th. The company reported ($7.28) earnings per share for the quarter, missing analysts' consensus estimates of ($3.92) by $3.36. The business earned $4.31 million during the quarter, compared to analyst estimates of $4.17 million. Neurometrix had a negative net margin of 124.01% and a negative return on equity of 181.47%. View Neurometrix's Earnings History.

Where is Neurometrix's stock going? Where will Neurometrix's stock price be in 2017?

2 brokers have issued 12-month target prices for Neurometrix's shares. Their predictions range from $36.00 to $36.00. On average, they anticipate Neurometrix's share price to reach $36.00 in the next twelve months. View Analyst Ratings for Neurometrix.

Who are some of Neurometrix's key competitors?

Some companies that are related to Neurometrix include Xtant Medical Holdings (XTNT), Ritter Pharmaceuticals (RTTR), Bioblast Pharma Ltd (ORPN), Apricus Biosciences (APRI), Strata Skin Sciences (SSKN), Acura Pharmaceuticals (ACUR), Transgenomic (TBIO), Sunshine Heart (SSH), Ampliphi Biosciences Corp (APHB), Opexa Therapeutics (OPXA), InspireMD (NSPR), Rosetta Genomics (ROSG), Prana Biotechnology Limited (PRAN), Delcath Systems (DCTH), Affymax (AFFY), Dextera Surgical (DXTR), Tetralogic Pharmaceuticals Corp (TLOG) and Adeptus Health (ADPT).

Who owns Neurometrix stock?

Neurometrix's stock is owned by a number of of institutional and retail investors. Top institutional investors include Sabby Management LLC (2.98%). Company insiders that own Neurometrix stock include Francis X Mcgillin, Shai Gozani and Thomas T Higgins. View Institutional Ownership Trends for Neurometrix.

Who bought Neurometrix stock? Who is buying Neurometrix stock?

Neurometrix's stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC. Company insiders that have bought Neurometrix stock in the last two years include Francis X Mcgillin, Shai Gozani and Thomas T Higgins. View Insider Buying and Selling for Neurometrix.

How do I buy Neurometrix stock?

Shares of Neurometrix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Neurometrix stock cost?

One share of Neurometrix stock can currently be purchased for approximately $3.45.

Consensus Ratings for Neurometrix (NASDAQ:NURO) (?)

Ratings Breakdown:	2 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$36.00 (943.48% upside)

Analysts' Ratings History for Neurometrix (NASDAQ:NURO)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
10/23/2016	HC Wainwright	Reiterated Rating	Buy	$36.00	N/A
10/21/2016	Rodman & Renshaw	Reiterated Rating	Buy	$36.00	N/A
2/29/2016	Dawson James	Reiterated Rating	Buy		N/A
9/11/2015	Maxim Group	Initiated Coverage	Buy	$64.00	N/A

(Data available from 5/27/2015 forward)

Earnings History for Neurometrix (NASDAQ:NURO)

Earnings by Quarter for Neurometrix (NASDAQ:NURO)

Earnings History by Quarter for Neurometrix (NASDAQ:NURO)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/20/2017	Q1 2017	($3.92)	($7.28)	$4.17 million	$4.31 million	View	N/A
1/26/2017	Q416	($6.00)	($4.16)	$3.48 million	$3.70 million	View	Listen
10/20/2016	Q316	($6.56)	($6.08)	$3.01 million	$3.39 million	View	Listen
7/21/2016	Q216	($7.44)	($42.96)	$1.22 million	$2.65 million	View	Listen
4/21/2016	Q116	($7.60)	($8.00)	$2.65 million	$2.28 million	View	Listen
10/22/2015	Q315	($0.64)	($2.08)	$6.47 million	$2.10 million	View	Listen
7/22/2015	Q215		($3.84)	$9.80 million	$1.22 million	View	Listen
2/12/2015	Q414		($2.88)	$4.62 million	$1.41 million	View	N/A
7/24/2014	Q413		($6.80)	$1.16 million	$1.34 million	View	N/A
2/13/2014			($6.96)			View	Listen
10/23/2013	Q313		($2.08)	$1.77 million	$1.31 million	View	Listen
7/25/2013	Q2 2013		($7.36)	$2.20 million	$1.20 million	View	N/A
2/3/2011		($1.36)	($1.44)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Neurometrix (NASDAQ:NURO)

Current Year EPS Consensus Estimate: $-10.50 EPS
Next Year EPS Consensus Estimate: $-2.73 EPS

Dividend History for Neurometrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Neurometrix (NASDAQ:NURO)

Insider Ownership Percentage: 5.90%
Institutional Ownership Percentage: 6.14%

Institutional Ownership by Quarter for Neurometrix (NASDAQ:NURO)

Insider Trades by Quarter for Neurometrix (NASDAQ:NURO)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
11/1/2016	Shai Gozani	CEO	Buy	3,000	$1.31	$3,930.00
10/28/2016	Thomas T Higgins	Insider	Buy	3,000	$1.32	$3,960.00
10/27/2016	Shai Gozani	CEO	Buy	6,000	$1.32	$7,920.00
8/31/2016	Thomas T Higgins	CFO	Buy	1,400	$1.41	$1,974.00
8/18/2016	Shai Gozani	CEO	Buy	5,000	$1.49	$7,450.00
8/12/2016	Thomas T Higgins	Insider	Buy	2,000	$1.45	$2,900.00
6/1/2016	Shai Gozani	CEO	Buy	2,500	$1.71	$4,275.00
5/23/2016	Francis X Mcgillin	VP	Buy	1,000	$1.65	$1,650.00
5/19/2016	Shai Gozani	CEO	Buy	12,000	$1.55	$18,600.00
5/19/2016	Thomas T Higgins	CFO	Buy	3,200	$1.54	$4,928.00
8/28/2015	Thomas T Higgins	CFO	Buy	4,500	$0.92	$4,140.00
8/20/2015	Thomas T Higgins	CFO	Buy	5,500	$0.91	$5,005.00
8/11/2015	Shai Gozani	CEO	Buy	16,300	$0.91	$14,833.00
11/9/2012	Shai Gozani	CEO	Buy	26,800	$0.55	$14,740.00
8/27/2012	Krishnamurthy Balachandran	COO	Buy	5,000	$0.67	$3,350.00
8/21/2012	Thomas T Higgins	CFO	Buy	5,000	$0.64	$3,200.00
8/13/2012	Krishnamurthy Balachandran	COO	Buy	5,000	$0.70	$3,500.00
8/8/2012	Thomas T Higgins	CFO	Buy	5,000	$0.70	$3,500.00

(Data available from 1/1/2013 forward)

Headline Trends for Neurometrix (NASDAQ:NURO) Latest Headlines for Neurometrix (NASDAQ:NURO)

Source:

Date	Headline
	NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology finance.yahoo.com - May 22 at 6:10 PM
	Neurometrix Inc (NURO) Upgraded to Hold at Zacks Investment Research www.americanbankingnews.com - May 18 at 2:50 PM
	NeuroMetrix Wins SBANE New England Innovation Award finance.yahoo.com - May 17 at 6:52 PM
	NeuroMetrix (NURO) Says Preliminary Results from Study Evaluating Quell in Chemotherapy-Induced Peripheral Neuropathy to be Presented at APS Meeting www.streetinsider.com - May 16 at 10:10 AM
	NeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain finance.yahoo.com - May 16 at 10:10 AM
	Preliminary Results from Clinical Study Evaluating Use of Quell in Chemotherapy-Induced Peripheral Neuropathy to be presented at the American Pain Society Annual Meeting finance.yahoo.com - May 15 at 6:14 PM
	NeuroMetrix (NURO) Declares 1-for-8 Reverse Stock Split www.streetinsider.com - May 13 at 8:20 AM
	NeuroMetrix Announces One-for-Eight Reverse Split finance.yahoo.com - May 11 at 7:24 PM
	NeuroMetrix (NURO) Announces Expansion of International Intellectual Property Assets for Quell www.streetinsider.com - May 8 at 6:24 PM
	NeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology www.businesswire.com - May 8 at 12:15 PM
	NeuroMetrix Hosts Inaugural Quell User Event finance.yahoo.com - May 5 at 7:11 PM
	Neurometrix (NURO) Getting Somewhat Positive Media Coverage, Analysis Finds www.americanbankingnews.com - May 3 at 3:24 PM
	Neurometrix (NURO) Earns Daily News Sentiment Score of 0.04 www.americanbankingnews.com - April 29 at 11:59 AM
	Neurometrix (NURO) Earning Somewhat Favorable Press Coverage, Analysis Finds www.americanbankingnews.com - April 26 at 12:28 PM
	Neurometrix Inc (NURO) Short Interest Update www.americanbankingnews.com - April 25 at 8:24 PM
	Neurometrix (NURO) Earns Daily Media Sentiment Score of 0.22 www.americanbankingnews.com - April 21 at 8:08 PM
	NeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2017 By the Numbers : April 21, 2017 finance.yahoo.com - April 21 at 6:49 PM
	Neurometrix Inc (NURO) Releases Earnings Results www.americanbankingnews.com - April 21 at 1:17 PM
	Edited Transcript of NURO earnings conference call or presentation 20-Apr-17 12:00pm GMT finance.yahoo.com - April 21 at 12:00 AM
	NeuroMetrix Reports Q1 2017 Financial Results finance.yahoo.com - April 20 at 9:22 AM
	NeuroMetrix Review Ahead of Thursday's Earnings Call finance.yahoo.com - April 19 at 10:11 AM
	NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Bed Bath & Beyond finance.yahoo.com - April 18 at 6:16 PM
	Somewhat Positive News Coverage Extremely Likely to Impact Neurometrix (NURO) Share Price www.americanbankingnews.com - April 18 at 2:52 PM
	Neurometrix Inc (NURO) to Release Quarterly Earnings on Wednesday www.americanbankingnews.com - April 17 at 9:22 AM
	NeuroMetrix Named a 50+ Innovation Leader finance.yahoo.com - April 13 at 6:42 PM
	Favorable Press Coverage Extremely Likely to Effect Neurometrix (NURO) Stock Price www.americanbankingnews.com - April 13 at 12:24 PM
	NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call - Business Wire (press release) www.businesswire.com - April 12 at 7:51 PM
	NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call finance.yahoo.com - April 12 at 7:51 PM
	Neurometrix Inc (NURO) Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - March 30 at 9:04 AM
	NeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting finance.yahoo.com - March 15 at 7:06 PM
	Neurometrix Inc (NURO) Upgraded to “Buy” by Zacks Investment Research www.americanbankingnews.com - March 9 at 1:28 AM
	NeuroMetrix Gaining Increased Media Coverage of Quell Wearable Pain Relief Technology in 2017 finance.yahoo.com - March 1 at 7:04 PM
	NEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders biz.yahoo.com - February 28 at 6:59 PM
	NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy finance.yahoo.com - February 21 at 5:57 PM
	NEUROMETRIX, INC. Financials finance.yahoo.com - February 16 at 6:30 PM
	NEUROMETRIX, INC. Financials finance.yahoo.com - February 16 at 6:30 PM
	NEUROMETRIX, INC. Files SEC form 10-K, Annual Report biz.yahoo.com - February 9 at 7:59 PM
	NEUROMETRIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; biz.yahoo.com - February 8 at 7:51 PM
	NeuroMetrix Reports Q4 and Full Year 2016 Financial Results us.rd.yahoo.com - January 26 at 11:44 PM
	Q4 2016 NeuroMetrix Inc Earnings Release - Before Market Open us.rd.yahoo.com - January 26 at 11:44 PM
	NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit us.rd.yahoo.com - January 26 at 11:43 PM
	7:20 am NeuroMetrix reports Q4 results; rev +36% y/y to $3.7 mln us.rd.yahoo.com - January 26 at 11:43 PM
	NeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today biz.yahoo.com - January 26 at 11:43 PM
	NeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call finance.yahoo.com - January 20 at 7:44 PM
	7:01 am NeuroMetrix reports Q4 demand for its Quell Technology, invoiced value of shipments totaled approximately $3.5 mln (+19% Q/Q) finance.yahoo.com - January 10 at 7:49 PM
	NeuroMetrix says Quell up 19% sequentially in Q4 - Seeking Alpha seekingalpha.com - January 10 at 8:54 AM
	NeuroMetrix Reports Strong Quell Demand in Q4 2016 finance.yahoo.com - January 10 at 8:54 AM
	CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain us.rd.yahoo.com - January 3 at 10:13 PM
	NeuroMetrix to Present at Biotech Showcase 2017 - Business Wire (press release) www.businesswire.com - January 3 at 5:11 PM
	NeuroMetrix (NURO) Enters $7M Private Placement of Preferred ... - StreetInsider.com www.streetinsider.com - December 28 at 11:49 PM